TOUYUN BIOTECH (01332) Surges Over 80% Intraday After Securing RMB 1 Billion Chlorella Product Orders

Stock News

Nov 12, 2025

TOUYUN BIOTECH (01332), which had seen consecutive declines in previous trading sessions, surged over 80% intraday. At the time of writing, the stock was up 54.47% to HK$0.38, with a turnover of HK$12.06 million.

The rally follows the company's recent announcement that its wholly-owned subsidiary, Shanxi Touyun, signed strategic cooperation agreements on October 23 with Shenzhen Louyujian Supply Chain Technology, Henan Guozitou Marketing Management, and Beijing Hewanjia Biotechnology. Under the agreements, the purchasing consortium will procure chlorella and related products worth no less than RMB 1 billion from Shanxi Touyun between 2026 and 2028.

In November 2024, TOUYUN BIOTECH obtained new usage approval from China's National Health Commission for its chlorella products. The group's chlorella production has expanded into new applications, including artificial fish, shrimp, and plant-based milk markets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1120007486"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120007486\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120007486?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 15:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120007486","market":"sh","top_or_hot":-1,"title":"TOUYUN BIOTECH (01332) Surges Over 80% Intraday After Securing RMB 1 Billion Chlorella Product Orders","media":"Stock News","content":"<p>TOUYUN BIOTECH (01332), which had seen consecutive declines in previous trading sessions, surged over 80% intraday. At the time of writing, the stock was up 54.47% to HK$0.38, with a turnover of HK$12.06 million.</p>\n<p>The rally follows the company's recent announcement that its wholly-owned subsidiary, Shanxi Touyun, signed strategic cooperation agreements on October 23 with Shenzhen Louyujian Supply Chain Technology, Henan Guozitou Marketing Management, and Beijing Hewanjia Biotechnology. Under the agreements, the purchasing consortium will procure chlorella and related products worth no less than RMB 1 billion from Shanxi Touyun between 2026 and 2028.</p>\n<p>In November 2024, TOUYUN BIOTECH obtained new usage approval from China's National Health Commission for its chlorella products. The group's chlorella production has expanded into new applications, including artificial fish, shrimp, and plant-based milk markets.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TOUYUN BIOTECH (01332) Surges Over 80% Intraday After Securing RMB 1 Billion Chlorella Product Orders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTOUYUN BIOTECH (01332) Surges Over 80% Intraday After Securing RMB 1 Billion Chlorella Product Orders\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-12 15:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TOUYUN BIOTECH (01332), which had seen consecutive declines in previous trading sessions, surged over 80% intraday. At the time of writing, the stock was up 54.47% to HK$0.38, with a turnover of HK$12.06 million.</p>\n<p>The rally follows the company's recent announcement that its wholly-owned subsidiary, Shanxi Touyun, signed strategic cooperation agreements on October 23 with Shenzhen Louyujian Supply Chain Technology, Henan Guozitou Marketing Management, and Beijing Hewanjia Biotechnology. Under the agreements, the purchasing consortium will procure chlorella and related products worth no less than RMB 1 billion from Shanxi Touyun between 2026 and 2028.</p>\n<p>In November 2024, TOUYUN BIOTECH obtained new usage approval from China's National Health Commission for its chlorella products. The group's chlorella production has expanded into new applications, including artificial fish, shrimp, and plant-based milk markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01332","symbol_name":"透云生物","start_time":0,"source_url":"","article_id":"1120007486","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120007486","pubTimestamp":1762932631,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"TOUYUN BIOTECH (01332), which had seen consecutive declines in previous trading sessions, surged over 80% intraday. At the time of writing, the stock was up 54.47% to HK$0.38, with a turnover of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01332":"透云生物","BK1157":"纸材料包装"},"translate_title":"斩获10亿小球藻产品订单后透云生物(01332)盘中大涨超80%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01332":1},"content_text":"TOUYUN BIOTECH (01332), which had seen consecutive declines in previous trading sessions, surged over 80% intraday. At the time of writing, the stock was up 54.47% to HK$0.38, with a turnover of HK$12.06 million.\nThe rally follows the company's recent announcement that its wholly-owned subsidiary, Shanxi Touyun, signed strategic cooperation agreements on October 23 with Shenzhen Louyujian Supply Chain Technology, Henan Guozitou Marketing Management, and Beijing Hewanjia Biotechnology. Under the agreements, the purchasing consortium will procure chlorella and related products worth no less than RMB 1 billion from Shanxi Touyun between 2026 and 2028.\nIn November 2024, TOUYUN BIOTECH obtained new usage approval from China's National Health Commission for its chlorella products. The group's chlorella production has expanded into new applications, including artificial fish, shrimp, and plant-based milk markets.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}